NUCLEOLAR AND ARGYROPHILIC NUCLEOLAR ORGANIZER REGION COUNTS IN UROTHELIAL CARCINOMAS WITH SPECIAL EMPHASIS ON GRADE-II TUMORS

被引:0
|
作者
HELPAP, B
LOESEVITZ, L
BULATKO, A
机构
关键词
TRANSITIONAL CELL CARCINOMA; NUCLEOLI; ARGYROPHILIC NUCLEOLAR ORGANIZER REGIONS;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Prognostic assessment of bladder carcinomas of intermediate differentiation is difficult. This study therefore investigated the prognostic values of nucleolar status and silver staining of argyrophilic nucleolar organizer regions (AgNORs) in grade II bladder carcinomas. In biopsies from 34 grade II transitional cell carcinomas of the urinary bladder the number of nuclei with nucleoli, the location of nucleoli within the nucleus and the number of AgNORs were determined in 1000 or 200 nuclei per section respectively. Ten biopsies showing normal urothelium, 18 cases with mild to severe atypia, 27 grade I, 34 grade II and 12 grade III transitional cell carcinomas were also studied. Significantly differing nucleolar and AgNOR values were found comparing normal urothelium/grade I carcinomas with severe urothelial atypia/grade III carcinomas. Grade II carcinomas, however, were inhomogeneous. One subgroup had nucleolar and AgNOR values resembling grade I carcinomas while the second group had values similar to those of grade III carcinomas. This subdivision of grade II carcinomas correlates with results reported for DNA-cytometry. The results suggest a subdivision of patients with grade II transitional cell carcinomas into a low risk and high risk group.
引用
收藏
页码:265 / 269
页数:5
相关论文
共 50 条
  • [21] ARGYROPHILIC NUCLEOLAR ORGANIZER REGION COUNTS AND KI-67 SCORES IN HUMAN RENAL-CELL CARCINOMA
    PICH, A
    VALENTE, G
    AZZONI, L
    STRAMIGNONI, A
    MARGARIA, E
    TASSO, M
    PATHOLOGY RESEARCH AND PRACTICE, 1991, 187 (04) : 482 - 486
  • [22] BREAST-CARCINOMA KINETICS - ARGYROPHILIC NUCLEOLAR ORGANIZER REGION COUNTS CORRELATE WITH KI67 SCORES
    DERVAN, PA
    GILMARTIN, LG
    LOFTUS, BM
    CARNEY, DN
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1989, 92 (04) : 401 - 407
  • [23] CORRELATION BETWEEN ARGYROPHILIC NUCLEOLAR ORGANIZER REGION COUNTS (AGNORS) AND DNA CONTENT IN BREAST-TUMOR IMPRINTS
    HIRSCHFIELD, LS
    HARRISON, G
    BHUIYA, T
    SONG, K
    LABORATORY INVESTIGATION, 1991, 64 (01) : A11 - A11
  • [24] Argyrophilic Nucleolar Organizer Region Counts in Exfoliative Cytology of Buccal Mucosa from Opium Addicts, Smokers and Nonsmokers
    Kadivar, Maryam
    Attar, Mehrnoush
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2008, 30 (05): : 274 - 278
  • [25] ARGYROPHILIC NUCLEOLAR ORGANIZER REGION PROTEINS (AG-NORS) IN HUMAN BRAIN-TUMORS - RELATIONS WITH GRADE OF MALIGNANCY AND PROLIFERATION INDEXES
    MAIER, H
    MORIMURA, T
    OFNER, D
    HALLBRUCKER, C
    KITZ, K
    BUDKA, H
    ACTA NEUROPATHOLOGICA, 1990, 80 (02) : 156 - 162
  • [26] Proliferative activity of esophageal carcinomas and their lymph node metastases: Comparison using argyrophilic nucleolar organizer region staining
    Yano, K
    Okamura, T
    Yoshida, Y
    Ichiyoshi, Y
    Yasumoto, K
    JOURNAL OF SURGICAL ONCOLOGY, 1997, 65 (04) : 274 - 279
  • [27] Role of argyrophilic nucleolar organizer region staining in identification of malignant cells in effusion
    Gill, Meenu
    Singh, Uma
    Mahapatra, Qury S.
    Gehlot, Sapna
    Gupta, Veena
    Sen, Rajeev
    JOURNAL OF CYTOLOGY, 2011, 28 (04) : 191 - 195
  • [28] Argyrophilic nucleolar organizer region (AgNOR) counting in astrocytic gliomas: Prognostic value
    Ferreres, JC
    Figols, J
    ValBernal, JF
    Cardesa, A
    Sanchez, FFC
    HISTOLOGY AND HISTOPATHOLOGY, 1996, 11 (01) : 35 - 39
  • [29] ARGYROPHILIC NUCLEOLAR ORGANIZER REGION COUNTS IN MULTIPLE-MYELOMA - A HISTOPATHOLOGICAL STUDY ON BONE-MARROW TREPHINE BIOPSIES
    PICH, A
    CHIUSA, L
    MARMONT, F
    CAPPELLO, N
    NAVONE, R
    VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1992, 421 (02) : 143 - 147
  • [30] Changes in histologic grade and argyrophilic nucleolar organizer regions during progression of prostate cancer
    Ohki, T
    Akakura, K
    Ueda, T
    Akimoto, S
    Yatani, R
    Shimazaki, J
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (02) : 82 - 87